This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Looking at the impact of the HEARTLINE trial and Apple Watch to detect Atrial Fibrillation

Ticker(s): AAPL, GOOG

Who's the expert?

I am retired from clincal medicine and no longer in practice. On the other hand, I have many publicatitions in peer-reviewed medical as well as engineering journals about atrial fibrillation, including many on its signal characteristics and automatic detection by devices and computers. I own an Apple Watch and have recorded my own ECG on it. My last publication, in Circulation, and quite relevant to the subject you are interested in, is about the clinical implications of brief afib episodes:

 

 

Swiryn, S, Orlov, MV, Benditt, DG, DiMarco, JP, Lloyd-Jones, DM, Karst, E, Qu, F, Slawsky, MT, Turkel, M, Waldo, AL, for the RATE Registry investigators: Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes (“The RATE Registry”). Circulation, 2016;134:1130-1140.

Interview Goal
Understanding the impact of smart watches and wearable technology to detect cardiac conditions such as Atrial Fibrilation.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.